Sharps technology regains compliance with nasdaq minimum bid price listing rule

New york, may 22, 2025 (globe newswire) -- sharps technology, inc. (nasdaq: “stss” and “stssw”) (“sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, announces that it has received a notice from nasdaq confirming that the company has regained compliance with the nasdaq's capital market's minimum bid price requirement of $1.00 per share and the minimum stockholders' equity requirement of $2.5 million.
NDAQ Ratings Summary
NDAQ Quant Ranking